PD18-07 PRIMARY CHEMOABLATION FOR THE TREATMENT OF LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA: THE OLYMPUS TRIAL

Nir Kleinmann,Surena F. Matin,Philip Pierorazio,John C. Gore,Ahmad Shabsigh,Brian Hu,Karim Chamie,Guilherme Godoy,Scott G. Hubosky,Marcelino E. Rivera,Michael OʼDonnell,Marcus L. Quek,Jay D. Raman,Douglas S. Scherr,Joshua M. Stern,Christopher J. Weight,Alon Z. Weizer,Michael Woods,Hristos Z. Kaimakliotis,Angela R. Smith,Jennifer Linehan,Jonathan A. Coleman,Mitchell R. Humphreys,David A. Lifshitz,Michael Verni,Elyse Seltzer,Ifat Klein,Marina Konorty,Dalit Strauss-Ayali,Gil Hakim,Mark P. Schoenberg,Seth P. Lerner

PD18-07 PRIMARY CHEMOABLATION FOR THE TREATMENT OF LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA: THE OLYMPUS TRIAL

2020

INTRODUCTION AND OBJECTIVE:Low grade (LG) upper tract urothelial cancer (UTUC) accounts for 40% of all UTUC diagnosed in the US. Although LG UTUC has a low risk of progression, radical nephroureter...

Keywords:

urothelial carcinoma
Urology
upper tract
Medicine
urothelial cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations